Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Steffen Tiedt et al, published in The Lancet Neurology:
”Biomarkers for Advancing Stroke Diagnosis and Prognosis
The complexity and incomplete understanding of stroke pathophysiology represent substantial challenges for personalized healthcare and the development of new therapies, as reflected in the neutral results of many randomized clinical trials.
Current clinical algorithms lack the precision needed to diagnose stroke before hospital admission, predict disease progression and recovery, or assess the risk of recurrence.
Biomarkers are urgently needed, but the absence of a robust evidence base hinders their clinical translation.
To lay the groundwork for filling this knowledge gap, an international multidisciplinary panel of stroke experts conducted a literature review that formed the basis for a Delphi consensus process.
The stroke expert panel proposes 17 research priorities and five minimum datasets for stroke biomarker studies, each corresponding to a key domain of stroke care: pre-hospital diagnosis, ischemic stroke progression, atrial heart disease, atherosclerotic plaque vulnerability, and intracerebral hemorrhage.
This framework will promote consistency and collaboration for the discovery, validation, and clinical translation of biomarkers to improve stroke care.”
Title: Biomarkers for advancing diagnosis and prognosis in stroke
Authors: Steffen Tiedt, Alejandro Bustamante, Alan Cameron, Pol Camps-Renom, Gerrit M Grosse, Johanna Ospel, Bastian Volbers, Heinrich J Audebert, Julia Aulin, Bastian Cheng, Charlotte Cordonnier, Jonathan M Coutinho, Ana Catarina Fonseca, Michael D Hill, Märit Jensen, Christina Jern, Joseph Kamtchum-Tatuene, Mira Katan, Peter J Kelly, Anna Kopczak, Robin Lemmens, Arne G Lindgren, James J M Loan, Christian H Nolte, Laurent Puy, Luca Saba, Rustam Al-Shahi Salman, Else Charlotte Sandset, Magdy H Selim, Pierre Seners, Nikola Sprigg, Hsin-Hsi Tsai, Karen M Doyle, Joan Montaner, Floris H B M Schreuder, Luciano Sposato, Neshika Samarasekera, John J McCabe on behalf of the BIOSTROKE investigators
Read the Full Article on The Lancet Neurology
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion